Banner

Division will focus on ophthalmic clinical trials

Article

Princeton, NJ-Advanced Biomedical Research Inc. has launched a new ophthalmic division, called ABR InVision, devoted to conducting clinical studies in glaucoma, retinal and corneal diseases, cataract, refractive surgery, and neuroprotection.

Related Videos
Related Content

FDA grants 510(k) clearance to Altris IMS platform

October 4th 2023

Eyepod: Ocugen CEO gives update on OCU400

October 2nd 2023

Treating dry eye and other ocular conditions may take a village

October 3rd 2023

EyePod: Week in Review - September 24, 2023

September 30th 2023

Dopavision completes enrollment in trial for the digital treatment of myopia

October 2nd 2023

Imaging outlines half-dose vs full-dose ultrawidefield fluorescein angiography

October 2nd 2023

FDA grants 510(k) clearance to Altris IMS platform

October 4th 2023

Eyepod: Ocugen CEO gives update on OCU400

October 2nd 2023

Treating dry eye and other ocular conditions may take a village

October 3rd 2023

EyePod: Week in Review - September 24, 2023

September 30th 2023

Dopavision completes enrollment in trial for the digital treatment of myopia

October 2nd 2023

Imaging outlines half-dose vs full-dose ultrawidefield fluorescein angiography

October 2nd 2023

FDA grants 510(k) clearance to Altris IMS platform

October 4th 2023

Eyepod: Ocugen CEO gives update on OCU400

October 2nd 2023

Treating dry eye and other ocular conditions may take a village

October 3rd 2023

EyePod: Week in Review - September 24, 2023

September 30th 2023

Dopavision completes enrollment in trial for the digital treatment of myopia

October 2nd 2023

Imaging outlines half-dose vs full-dose ultrawidefield fluorescein angiography

October 2nd 2023
© 2023 MJH Life Sciences

All rights reserved.